partnership

Sesh, MS Canada partner to help MS patients with mental health

To support the wellness journeys of Canadians living with multiple sclerosis (MS), digital healthcare company Sesh is partnering with MS Canada to provide free, unlimited access to its online mental health platform. The partnership allows patients to participate in virtual therapist-led support groups, and kickstarts research efforts…

Calyx, Qynapse to Expand Use of Neuroimaging AI Tools

Calyx and Qynapse have joined forces to expand the use of artificial intelligence (AI)-based neuroimaging tools in clinical trials of treatment candidates for conditions affecting the central nervous system (CNS), or the brain and spinal cord. This is expected to help advance therapy development for multiple sclerosis…

Biogen, MedRhythms Working on Music Therapy for MS Gait Issues

Biogen has entered a licensing agreementĀ to develop and potentially commercialize MedRhythms‘Ā investigational music-based digital therapy, MR-004, designed to help make walking easier for people with multiple sclerosis (MS). The partnership combines Biogenā€™s leadership and expertise in MS with MedRhythmsā€™ digital therapeutics platform that uses sensors, algorithms, and music…

Deal Brings AI-powered MRI to Care of Patients With Brain Disorders

A new collaboration between Arterys and Combinostics seeks to bring comprehensive artificial intelligence (AI) imaging solutions to the diagnosis and care of patients with multiple sclerosis (MS) and other neurological diseases. Under the partnership, Arterys will include Combinosticsā€™ AI-powered cNeuro on its medical imaging cloud AI platform…

Shepherd Center, BurnAlong Open Global Online Rehab Classes for MS

BurnAlong and theĀ Shepherd Center, a leading rehabilitation hospital in the U.S., have established a partnership to bring tailored rehabilitation classes to people withĀ multiple sclerosis (MS) and other neuromuscular diseases worldwide. The video classes, designed by clinicians, therapists, and wellness professionals at the Shepherd Center, based in Atlanta,…

Novartis, Pear Collaborating on Digital Therapeutics to Treat MS, Schizophrenia

Novartis and Pear Therapeutics are joining forces to develop novel prescription digital therapeutics to treat patients with schizophrenia and multiple sclerosis (MS). Digital therapeutics are software applications designed to treat diseases and improve clinical outcomes for patients.Ā Combining Novartisā€™ expertise in biomedical research and clinical development with Pearā€™s…